Aspire Orthopaedics Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 11593986 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2025

FOR

ASPIRE ORTHOPAEDICS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

A R Chitre

Mrs E A H Chitre

REGISTERED OFFICE:

Chandler House

7 Ferry Road Office Park

Riversway

Preston

Lancashire

PR2 2YH

REGISTERED NUMBER:

11593986 (England and Wales)

ACCOUNTANTS:

Wallwork Nelson & Johnson

Chandler House

7 Ferry Road Office Park

Riversway

Preston

Lancashire

PR2 2YH

FIXED ASSETS

Tangible assets

4

26,195

33,359

Investments

5

5,150

31,345

38,509

CURRENT ASSETS

Debtors

6

49,276

26,033

Cash at bank and in hand

24,693

58,505

73,969

84,538

CREDITORS

Amounts falling due within one year

7

23,108

27,321

NET CURRENT ASSETS

50,861

57,217

TOTAL ASSETS LESS CURRENT
LIABILITIES

82,206

95,726

CREDITORS

Amounts falling due after more than one
year

8

(937

)

(2,187

)

PROVISIONS FOR LIABILITIES

9

(870

)

(1,414

)

NET ASSETS

80,399

92,125

CAPITAL AND RESERVES

Called up share capital

10

100

Retained earnings

80,299

92,025

SHAREHOLDERS' FUNDS

80,399

92,125

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 March 2026 and were signed on its behalf by:

A R Chitre - Director

Mrs E A H Chitre - Director

1.	STATUTORY INFORMATION

Aspire Orthopaedics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Motor vehicles

-

20% on reducing balance

Computer equipment

-

25% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4.	TANGIBLE FIXED ASSETS

Motor

Computer

vehicles

equipment

Totals

£

COST

At 1 October 2024

and 30 September 2025

41,200

4,976

46,176

DEPRECIATION

At 1 October 2024

9,888

2,929

12,817

Charge for year

6,262

902

7,164

At 30 September 2025

16,150

3,831

19,981

NET BOOK VALUE

At 30 September 2025

25,050

1,145

26,195

At 30 September 2024

31,312

2,047

33,359

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 October 2024

and 30 September 2025

5,150

NET BOOK VALUE

At 30 September 2025

5,150

At 30 September 2024

5,150

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30/9/25

30/9/24

£

Other debtors

9,029

8,395

Directors' current accounts

37,247

14,825

Prepayments and accrued income

3,000

2,813

49,276

26,033

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30/9/25

30/9/24

£

Hire purchase contracts

1,250

Amounts owed to group undertakings

460

Tax

17,683

22,196

Other creditors

1,315

Accruals and deferred income

2,400

2,100

23,108

27,321

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

30/9/25

30/9/24

£

Hire purchase contracts

937

2,187

9.	PROVISIONS FOR LIABILITIES

30/9/25

30/9/24

£

Deferred tax

870

1,414

Deferred

tax

£

Balance at 1 October 2024

1,414

Credit to Income Statement during year

(544

)

Balance at 30 September 2025

870

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30/9/25

30/9/24

value:

£

55

Ordinary 'A'

£1

55

45

Ordinary 'B'

£1

45

100

11.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2025 and 30 September 2024:

30/9/25

30/9/24

£

A R Chitre and Mrs E A H Chitre

Balance outstanding at start of year

14,825

30,793

Amounts advanced

88,122

33,432

Amounts repaid

(65,700

)

(49,400

)

Amounts written off

-

Amounts waived

-

Balance outstanding at end of year

37,247

14,825